-
Abstract Number: PB0029
Safe Timely resumption of Pharmacologic thromboembolism prevention in Hospitalized patients with A Recent Major Bleed
-
Abstract Number: PB0434
Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: A systematic review and meta-analysis
-
Abstract Number: PB1366
Safety and Efficacy of Apixaban as Thromboprophylaxis in Multiple Myeloma Patients Receiving Chemotherapy: a Prospective Cohort Study
-
Abstract Number: PB0921
Safety and efficacy of direct oral anticoagulant in elderly patients with cancer: real-world challenges
-
Abstract Number: PB1187
Safety and Efficacy of Emicizumab During Dental Extraction in Haemophilia Patient
-
Abstract Number: OC 40.4
Safety and Efficacy of Emicizumab in People with Hemophilia A Enrolled in the Hemophilia Natural History Study (ATHN 7)
-
Abstract Number: OC 63.3
Safety and Efficacy of Recombinant Factor IX Fusion Protein (rIX-FP) in Previously Untreated Patients with Hemophilia B
-
Abstract Number: PB1126
Safety and efficacy of simoctocog alfa in patients with haemophilia A in routine clinical practice (GENA-99)
-
Abstract Number: PB1210
Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia (ITP).
-
Abstract Number: PB0672
Safety and pharmacokinetics of a subcutaneous recombinant FVIII (OCTA101) in adult patients with severe haemophilia A
-
Abstract Number: OC 70.2
Safety of Intramuscular COVID-19 Vaccination in Patients With Hemophilia
-
Abstract Number: PB1162
Safety of Non-Steroidal Anti-Inflammatory Drugs in hemophilia: a systematic review reporting on adverse bleeding and cardiovascular events
-
Abstract Number: OC 71.1
Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
-
Abstract Number: PB0067
Safety of Sinopharm covid-19 Vaccine in Iranian Patients with congenital bleeding disorders: A Preliminary Report
-
Abstract Number: OC 05.1
SARS-CoV-2 RBD and its variants can induce platelet activation and clearance: Implications for vaccinations and antibody therapy against COVID-19
-
Abstract Number: OC 57.1
SARS-CoV-2 Spike Protein Enhanced Thrombosis is inhibited by Tipiracil in Mice
-
Abstract Number: PO0005
Secondary prevention of cardiogenic arterial thromboembolism in a patient with atrial fibrillation and thrombus in left ventricule
-
Abstract Number: PB0352
Secretion of transforming growth factor β1 from megakaryocytes is mediated by autophagy signaling pathways
-
Abstract Number: VPB1277
Selective angiostatin neutralization promotes endothelial migration an early stage of angiogenesis
-
Abstract Number: OC 34.2
Selective serotonin reuptake inhibitor use is associated with major bleeding during treatment with vitamin K antagonists: results of a cohort study
-
Abstract Number: PB1399
Semiological assessment and use of scales in patients with excessive menstrual bleeding in primary care: a pending task.
-
Abstract Number: PB0096
Sera from donors of COVID-19 convalescent plasma do not induce procoagulant phenotype in platelets
-
Abstract Number: OC 23.2
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: data from the REVERSE cohort study
-
Abstract Number: VPB1348
Serial Platelet Mapping Can be Used to Define Platelet Hyperactivity Throughout Pregnancy
-
Abstract Number: PB0097
Serial thrombin generation, while on LMWH prophylaxis in critically ill COVID-19 patients from the prospective MaastrICCht cohort.
-
Abstract Number: VPB0366
Serial Thrombopoietin Levels in Immune Thrombocytopenia Patients on Treatment.
-
Abstract Number: PB0245
Series Review of Fetal/neonatal Alloimmune Thrombocytopenia Diagnosis, Management and Outcome in a Tertiary Care Centre
-
Abstract Number: OC 69.1
SERPIN-Inspired Nanomedicine Targeting to Activated Neutrophils Provides Safe and Effective Thromboprotection
-
Abstract Number: PB0074
Severe COVID-19 disease presentation is associated with significantly decreased levels of coagulation factor XIII
-
Abstract Number: PB1401
Severe Covid-19 Infection in Pregnancy complicated by Heparin Induced Thrombocytopenia
-
Abstract Number: VPB0761
Severe hemorrhage complicated with acute multiple cerebral infarction in a patient with thrombocytopenia caused by chemotherapy
-
Abstract Number: PB0065
Sex- and Age Specific Association of New-Onset Atrial Fibrillation with In-Hospital Mortality in Hospitalised COVID-19 Patients.
-
Abstract Number: PB1147
Sexism in Hemophilia? Identifying Disparities in Care of Symptomatic Hemophilia Carriers in a Comprehensive Hemophilia Treatment Center
-
Abstract Number: PB0537
Short-term biological variation study of hemophilia and thrombophilia parameters in a population of Caucasian adults
-
Abstract Number: PB0951
Shortened Prothrombin Time and activated Partial Thromboplastin Time Tests as a Risk Factor for Venous or Arterial Thrombosis in Mexico
-
Abstract Number: PB0360
SHP099 inhibits megakaryopoiesis, thrombopoiesis and Mpl signalling
-
Abstract Number: PB0749
Significance of platelet count at diagnosis and its association with survival in Myelodysplastic Syndrome patients; an experience from Pakistan
-
Abstract Number: OC 70.1
Similar Sports injuries in Dutch people with haemophilia and the general population: results of a 12-month prospective study
-
Abstract Number: PB0269
Single center case series & literature review: Deficiency of Adenosine Desaminase (DADA2) causes stroke, livedo racemosa, fever, lymphoproliferation, immunoglobulin deficiency&pancytopenia in children
-
Abstract Number: PB0417
Single Centre Experience of Lupus Anticoagulant Testing
-
Abstract Number: VPB0149
Single nucleotide polymorphisms of the HIF1A gene are associated with sensitivity of glucocorticoid treatment in pediatric ITP patients
-
Abstract Number: PB0869
Single platelet function in thrombocytopenia patients measured with droplet microfluidics
-
Abstract Number: LB 02.3
Sirtuin 1 as an endogenous inhibitor of NETosis
-
Abstract Number: PB0348
Small-molecule cyclophilin inhibitors as a potential therapeutic application to limit thrombosis
-
Abstract Number: PB0861
Smartphone-based detection of platelet response to ADP in microcapillary strips
-
Abstract Number: PB0860
Smartphone-based detection of the coagulation cascade and/or platelet activation in ‘dip-stick’ microcapillary strips
-
Abstract Number: PB0214
Snake venom-based hemocoagulase restores in vivo hemostasis and limits bleeding in murine model of hemophilia A
-
Abstract Number: VPB0024
Some Hemostasis Parameters Concentrations in Coronary Artery Disease Patients depending on Arrhythmias
-
Abstract Number: PB0038
Sources of heterogeneity in studies reporting the venous thrombotic risk in patients admitted with COVID-19: a meta-analysis and explorative meta-regression
-
Abstract Number: OC 09.4
Spatial transcriptomics reveals megakaryocyte heterogeneity in mouse bone marrow
-
Abstract Number: OC 49.2
Spatio-temporal control of fibrin formation by platelet glycoprotein V
-
Abstract Number: PB0069
Splanchnic vein thrombosis and Budd-Chiari syndrome after SARS-CoV-2 vaccination – incidence of VITT
-
Abstract Number: OC 51.4
Spleen Tyrosine Kinase Activation Drives Platelet Procoagulation in Antiphospholipid Syndrome During Pregnancy
-
Abstract Number: PO0038
Sporadic Hemophilia – When Family History Offers No Clues
-
Abstract Number: PB0830
Sporadic Type 3 von Willebrand Disease due to homozygosity in a non-consanguineous family
-
Abstract Number: PB0198
Stable Binding to Phosphatidylserine-containing Membranes Requires Conserved Arginine Residues in Tandem C Domains of Blood Coagulation Factor VIII
-
Abstract Number: PB0061
Standard dosing of Enoxaparin Versus unfractionated heparin in critically ill COVID19 patients: A Multicenter Cohort Study
-
Abstract Number: VPB1115
State-of-the-art for Coagulation Factors Activity Assays Evaluated from Results of an External Quality Assessment Program
-
Abstract Number: PB0606
Stimulation of the ssRNA virus immune receptor, Toll-like receptor 7, on megakaryocytes increases thrombopoesis.
-
Abstract Number: PB0893
Storage of apheresis platelets in lipaemic plasma affects aspects of platelet function and surface receptor expression
-
Abstract Number: OC 46.1
Streptococcal Surface Enolase (SEN) is Overshadowed by Plasminogen-binding Group A Streptococcal M-protein (PAM) for Human Plasminogen Acquisition and Activation
-
Abstract Number: VPB0639
Strong Fibrinolysis with New Fermented Foods (Mung Bean Natto and Natto Miso)
-
Abstract Number: PB0535
Structural basis of activated factor X binding to antithrombin not activated by heparinoids, insights from enhanced sampling molecular dynamics simulations
-
Abstract Number: PO0062
Studies of congenital thrombophilia: experience of the University Hospital Center of Oran in Algeria
-
Abstract Number: OC 78.1
Study of missense changes involving cysteine residues in F11: implications on folding, dimerization, activity and FXI deficiency
-
Abstract Number: PB0450
Study of the thrombin generation in anticoagulated patients with hemorrhage complications
-
Abstract Number: PB1309
Study the role of endothelial protein C receptor gene polymorphisms in Indian DVT patients
-
Abstract Number: OC 53.1
Studying VWF secretion under flow using microfluidics and patient-derived endothelial cells
-
Abstract Number: OC 74.1
Substitution of the Factor IX Activation Sites for Characterization of the Factor IX Activation Pathway and Partially Activated Intermediates
-
Abstract Number: VPB0372
Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism
-
Abstract Number: PB0275
Successful off-label use of intra-arterial eptifibatide followed by ticagrelor in a pediatric acute arterial ischemic stroke patient
-
Abstract Number: PO0030
Successful Treatment of Disseminated Intravascular Coagulation (DIC) in Patients with Obstetric Pathology and Acute Promyelocytic Leukemia (APL): A Case Series
-
Abstract Number: PO0013
Sudden onset of spontaneous extensive skin bruising, based on acquired haemophilia A, associated with a COVID-19 infection
-
Abstract Number: OC 61.4
Supercharged platelets as a novel therapy for reducing blood loss post-cardiac surgery
-
Abstract Number: OC 52.5
Superficial venous thrombosis of the lower extremities during pregnancy and post partum: a Danish population-based cohort study
-
Abstract Number: PB0783
Suramin is a Hepsin inhibitor which reduces its protumor and prothrombotic effects in colorectal cancer cells
-
Abstract Number: OC 29.2
Surface exposure of cellular factor XIII on activated platelets and platelet microparticles is unrelated to the elevation of cytoplasmic Ca2+ concentration
-
Abstract Number: PB0865
Surfing the PHOME for Novel Anti-Platelet Agents: Empirical Evaluation of a Bioinformatic Drug Re-Purposing Algorithm
-
Abstract Number: PB0932
Survey on the management of cancer associated thrombosis (CAT) in haemato-oncology patients with thrombocytopenia
-
Abstract Number: PB1009
Synergistic Effect of the Factor XIa Inhibitor Milvexian with Heparin But Not Bivalirudin in Activated Clotting Time Assays in Human Whole Blood In Vitro
-
Abstract Number: OC 24.1
Synergy of red blood cells and tranexamic acid in the inhibition of fibrinolysis
-
Abstract Number: OC 53.3
Syntaxin-2 deficiency results in reduced von Willebrand factor expression in vitro and in vivo
-
Abstract Number: PB0755
Synthetic Bcr-Abl tyrosine kinase inhibitors; their profile towards antiplatelet activity and cancer cell functionality
-
Abstract Number: OC 69.4
Synthetic microRNA switch technology enables to detect the immune-biased megakaryocytes from heterogenous iPSC-derived megakaryocyte progenitor cell lines
-
Abstract Number: VPB1420
Systemic and local changes in the tissue factor activity and its inhibitor in early severe preeclampsia
ISTH 2022 Congress
July 9-13, 2022. London, England, UK.